Evaluation of Valvular Heart Disease Using Cardiac CT
Recruiting
- Conditions
- Valvular Heart Disease
- Registration Number
- NCT06937125
- Lead Sponsor
- Toho University
- Brief Summary
The EVIDENTIA Registry is a multicenter study designed to evaluate valvular heart disease (VHD) using cardiac CT. It aims to assess cardiac valve anatomy, function, and myocardial characteristics through detailed CT analysis.
1. Assessing the accuracy of cardiac CT in evaluating cardiac structure, volume, function, and myocardium in VHD patients.
2. Comparing the severity, classification, and etiology (primary vs. functional) of VHD.
3. Monitoring serial changes in VHD severity via echocardiography.
4. Investigating the relationship between echocardiographic and CT-derived parameters.
5. Examining the correlation between imaging findings, VHD interventions, and patient prognosis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 350
Inclusion Criteria
- Patients with at least moderate valvular heart disease who had a cardiac CT with 64 or more rows
- 18 years of age or older
Exclusion Criteria
- Less than 18 years old
- Acute VHD
- Infectious endocarditis
- Patients with post-VHD intervention
- Poor CT image quality for analyzing CT data.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the 1-year composite endpoint of all-cause death and major cardiac adverse events (MACE) including VHD intervention. one year
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Toho University
🇯🇵Ota, Tokyo, Japan